$0.4063
0.00150.37%
Last update: Nov 2, 7:35 PM
Lucid Diagnostics Inc (LUCD) Stock Price, Quote, News & History
LUCDNASDAQ
RingCentral surged 15% after beating Q3 estimates and raising FY26 guidance; XXII, LABT and HUBC led premarket gainers, while LNAI fell.
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Lucid Diagnostics has a consensus price target of $3.67.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.41 last updated November 2, 2026 at 7:35 PM EST.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics does not have any upcoming earnings scheduled.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of...
